Cannabis and psychiatric disorders: it is not only addiction

Comorbidity of Mental Disorders With Alcohol and Other Drug Abuse: Results From the Epidemiologic Catchment Area (ECA) Study

Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962 · see citing works

Cannabinoid receptor localization in brain.

Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321 · see citing works

The endogenous cannabinoid system controls extinction of aversive memories

Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728 · see citing works

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction

Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409 · see citing works

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.

Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399 · see citing works

Modulation of anxiety through blockade of anandamide hydrolysis

Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293 · see citing works

Endocannabinoid Signaling in the Brain

Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,260 · see citing works

Cannabis and schizophrenia. A longitudinal study of Swedish conscripts

Andréasson, S., Engström, A., Allebeck, P., & Rydberg, U. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92620-1 · Cited by 1,166 · see citing works

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

Glass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052 · see citing works

The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis

D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024 · see citing works

Cannabis use and mental health in young people: cohort study.

Patton, G. C., Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M., & Hall, W. (2002) · BMJ · doi:10.1136/bmj.325.7374.1195 · Cited by 997 · see citing works

Cannabis use and psychosis: A longitudinal population-based study

van Os, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf043 · Cited by 928 · see citing works

Causal association between cannabis and psychosis: examination of the evidence

Arseneault, L., Cannon, M. D., Witton, J., & Murray, R. M. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.184.2.110 · Cited by 909 · see citing works

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study

Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002) · BMJ · doi:10.1136/bmj.325.7374.1199 · Cited by 871 · see citing works

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

Giuffrida, A., Parsons, L. H., Kerr, T. M., de Fonseca, F. R., Navarro, M. A., & Piomelli, D. (1999) · Nature Neuroscience · doi:10.1038/7268 · Cited by 771 · see citing works

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

Henquet, C., Krabbendam, L., Spauwen, J., Kaplan, C., Lieb, R., Wittchen, H.-U., & van Os, J. (2005) · BMJ · doi:10.1136/bmj.38267.664086.63 · Cited by 765 · see citing works

Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

Gobbi, G., Bambico, F. R., Mangieri, R. A., Bortolato, M., Campolongo, P., Solinas, M., Cassano, T., Morgese, M. G., Debonnel, G., Duranti, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509591102 · Cited by 676 · see citing works

Cannabis Abuse and the Course of Recent-Onset Schizophrenic Disorders

LINSZEN, D. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040017002 · Cited by 665 · see citing works

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

D’Souza, D. C., Abi-Saab, W. M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T. B., & Krystal, J. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.006 · Cited by 617 · see citing works

Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects

Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608 · see citing works

Exploring the association between cannabis use and depression.

Degenhardt, L., Hall, W., & Lynskey, M. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00437.x · Cited by 587 · see citing works

Cannabis use and psychosocial adjustment in adolescence and young adulthood

Fergusson, D. M., Horwood, L. J., & Swain‐Campbell, N. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00103.x · Cited by 563 · see citing works

Presynaptic Inhibition Caused by Retrograde Signal from Metabotropic Glutamate to Cannabinoid Receptors

Maejima, T., Hashimoto, K., Yoshida, T., Aiba, A., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00375-0 · Cited by 556 · see citing works

Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects

Jiang, W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25509 · Cited by 527 · see citing works

Cannabidiol: An Overview of Some Pharmacological Aspects

Mechoulam, R., Parker, L. A., & Gallily, R. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb05998.x · Cited by 511 · see citing works

Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence

Buckner, J. D., Schmidt, N. B., Lang, A. R., Small, J. W., Schlauch, R. C., & Lewinsohn, P. M. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.01.002 · Cited by 506 · see citing works

Health aspects of cannabis

Hollister, L. E. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90030-4 · Cited by 500 · see citing works

Endocannabinoid system and stress and anxiety responses

VIVEROS, M., MARCO, E., & FILE, S. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.029 · Cited by 485 · see citing works

The Consequences in Young Adulthood of Adolescent Drug Involvement

Kandel, D. B. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800080032005 · Cited by 484 · see citing works

Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms

Giuffrida, A., Leweke, F. M., Gerth, C. W., Schreiber, D., Koethe, D., Faulhaber, J., Klosterkötter, J., & Piomelli, D. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300558 · Cited by 481 · see citing works

Cannabis Abuse as a Risk Factor for Depressive Symptoms

BOVASSO, G. B. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2033 · Cited by 455 · see citing works

Elevated endogenous cannabinoids in schizophrenia

Leweke, F. M., Giuffrida, A., Wurster, U., Emrich, H. M., & Piomelli, D. (1999) · Neuroreport · doi:10.1097/00001756-199906030-00008 · Cited by 431 · see citing works

Chronic Pubertal, but not Adult Chronic Cannabinoid Treatment Impairs Sensorimotor Gating, Recognition Memory, and the Performance in a Progressive Ratio Task in Adult Rats

Schneider, M., & Koch, M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300225 · Cited by 425 · see citing works

Metabotropic Glutamate Receptors Drive the Endocannabinoid System in Hippocampus

Varma, N., Carlson, G. C., Ledent, C. A., & Alger, B. E. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-24-j0003.2001 · Cited by 407 · see citing works

Evidence for novel cannabinoid receptors

Begg, M., Pacher, P., Bátkai, S., Osei‐Hyiaman, D., Offertáler, L., Mo, F.-M., LIU, J., & Kunos, G. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.005 · Cited by 385 · see citing works

Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use

Dean, B., Sundram, S., Bradbury, R., Scarr, E., & Copolov, D. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00552-2 · Cited by 381 · see citing works

Effects of ipsapirone and cannabidiol on human experimental anxiety

Zuardi, A. W., Cosme, R. A., Graeff, F. G., & Guimarães, F. S. (1993) · Journal of Psychopharmacology · doi:10.1177/026988119300700112 · Cited by 364 · see citing works

The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety

Haller, J., Bakos, N., Szirmay, M., Ledent, C., & Freund, T. F. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02192.x · Cited by 354 · see citing works

In silico patent searching reveals a new cannabinoid receptor

Baker, D., Pryce, G., Davies, W. I. L., & Hiley, C. R. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.003 · Cited by 347 · see citing works

Antidepressant-like Activity of the Fatty Acid Amide Hydrolase Inhibitor URB597 in a Rat Model of Chronic Mild Stress

Bortolato, M., Mangieri, R. A., Fu, J., Kim, J. H., Arguello, O., Duranti, A., Tontini, A., Mor, M., Tarzia, G., & Piomelli, D. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.001 · Cited by 347 · see citing works

Placebo-Controlled Evaluation of Four Novel Compounds for the Treatment of Schizophrenia and Schizoaffective Disorder

Meltzer, H. Y., Arvanitis, L. A., Bauer, D., Rein, W., & Meta-Trial Study Group (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.975 · Cited by 330 · see citing works

The endocannabinoid system drives neural progenitor proliferation

Aguado, T., Monory, K., Palazuelos, J., Stella, N., Cravatt, B. F., Lutz, B., Marsicano, G., Kokaia, Z., Guzmán, M., & Galve‐Roperh, I. (2005) · The FASEB Journal · doi:10.1096/fj.05-3995fje · Cited by 327 · see citing works

Impact of complex genetic variation in COMT on human brain function

Meyer‐Lindenberg, A., Nichols, T. E., Callicott, J. H., Ding, J., Kolachana, B. S., Buckholtz, J. W., Mattay, V. S., Egan, M. F., & Weinberger, D. R. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001860 · Cited by 321 · see citing works

Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents

Wittchen, H.-U., Fröhlich, C., Behrendt, S., Günther, A., Rehm, J., Zimmermann, P., Lieb, R., & Perkonigg, A. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.12.013 · Cited by 311 · see citing works

Longitudinal study of co-occurring psychiatric disorders and substance use.

BROOK, J. S., COHEN, P., & BROOK, D. W. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199803000-00018 · Cited by 308 · see citing works

Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat

Navarro, M., Hernández, E., Muñoz, R. M., del Arco, I., Villanúa, M. Á., Carrera, M. R. A., & de Fonseca, F. R. (1997) · Neuroreport · doi:10.1097/00001756-199701200-00023 · Cited by 306 · see citing works

A longitudinal study of cannabis use and mental health from adolescence to early adulthood

McGee, R. O., Williams, S., Poulton, R., & Moffitt, T. E. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.9544912.x · Cited by 298 · see citing works

Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor

Berghuis, P., Dobszay, M. B., Wang, X., Spano, S., Ledda, F., Sousa, K. M., Schulte, G., Ernfors, P., Mackie, K., Paratcha, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509494102 · Cited by 291 · see citing works

The Endocannabinoid System Promotes Astroglial Differentiation by Acting on Neural Progenitor Cells

Aguado, T., Palazuelos, J., Monory, K., Stella, N., Cravatt, B. F., Lutz, B., Marsicano, G., Kokaia, Z., Guzmán, M., & Galve‐Roperh, I. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3101-05.2006 · Cited by 269 · see citing works

Cannabis and Anxiety and Depression in Young Adults

Hayatbakhsh, M. R., Najman, J. M., Jamrozik, K. D., Mamun, A. A., Alati, R., & Bor, W. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31802dc54d · Cited by 266 · see citing works

Cannabis Use and Age at Onset of Schizophrenia

Veen, N. D., Selten, J., van der Tweel, I., Feller, W., Hoek, H. W., & Kahn, R. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.501 · Cited by 266 · see citing works

Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia

Zavitsanou, K., Garrick, T. M., & Huang, X. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.11.005 · Cited by 264 · see citing works

Reasons for increased substance use in psychosis

Gregg, L., Barrowclough, C., & Haddock, G. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.09.004 · Cited by 249 · see citing works

CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents

Haller, J., Varga, B., Ledent, C., & Freund, T. F. (2004) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000135704.56422.40 · Cited by 241 · cited 1× · see citing works

Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use

Leweke, F. M., Giuffrida, A., Koethe, D., Schreiber, D., Nolden, B. M., Kranaster, L., Neatby, M. A., Schneider, M., Gerth, C. W., Hellmich, M., et al. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.04.025 · Cited by 240 · see citing works

The impact of substance abuse on the course of bipolar disorder

Strakowski, S. M., DelBello, M. P., Fleck, D. E., & Arndt, S. V. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00900-8 · Cited by 236 · see citing works

Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder

Mueser, K. T., Yarnold, P. R., & Bellack, A. S. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb01441.x · Cited by 229 · see citing works

Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system

Emrich, H. M., Leweke, F. M., & Schneider, U. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00426-1 · Cited by 226 · see citing works

Substance Abuse and Bipolar Affective Disorder

SONNE, S. C., BRADY, K. T., & MORTON, W. A. (1994) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199406000-00007 · Cited by 211 · see citing works

Major Depressive Disorder, Suicidal Ideation, and Suicide Attempt inTwins Discordant for Cannabis Dependence and Early-Onset Cannabis Use

Lynskey, M. T., Glowinski, A. L., Todorov, A. A., Bucholz, K. K., Madden, P. A. F., Nelson, E. C., Statham, D. J., Martin, N. G., & Heath, A. C. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.10.1026 · Cited by 198 · see citing works

Effects of cannabidiol in animal models predictive of antipsychotic activity

Zuardi, A. W., Antunes Rodrigues, J., & Cunha, J. M. (1991) · Psychopharmacology · doi:10.1007/bf02244189 · Cited by 191 · see citing works

Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression

Koethe, D., Llenos, I. C., Dulay, J. R., Hoyer, C., Torrey, Ε. F., Leweke, F. M., & Weis, S. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0660-5 · Cited by 187 · see citing works

Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia

Newell, K. A., Deng, C., & Huang, X. (2006) · Experimental Brain Research · doi:10.1007/s00221-006-0503-x · Cited by 179 · see citing works

Substance Use Disorder and the Early Course of Illness in Schizophrenia and Affective Psychosis

Kovasznay, B. M., Fleischer, J., Tanenberg‐Karant, M., Jandorf, L., Miller, A. D., & Bromet, E. J. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.2.195 · Cited by 177 · see citing works

Trends in the Development of New Antidepressants. Is there a Light at the End of the Tunnel?

Pacher, P., & Kecskeméti, V. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455594 · Cited by 176 · see citing works

Cannabis use and expression of mania in the general population

Henquet, C., A, L. K. M., de Graaf, R., ten Have, M., & van Os, J. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.05.002 · Cited by 176 · see citing works

Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters

Arévalo, C., de Miguel, R., & Hernández‐Tristán, R. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00578-0 · Cited by 175 · see citing works

Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors

Bilkei‐Gorzó, A., Rácz, I., Valverde, O., Otto, M., Michel, K., Sarstre, M., & Zimmer, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504640102 · Cited by 166 · see citing works

Effects of Co-occurring Cannabis Use Disorders on the Course of Bipolar Disorder After a First Hospitalization for Mania

Strakowski, S. M., DelBello, M. P., Fleck, D. E., Adler, C. M., Anthenelli, R. M., Keck, P. E., Arnold, L. M., & Amicone, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.1.57 · Cited by 165 · see citing works

Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala

Patel, S., Cravatt, B. F., & Hillard, C. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300535 · Cited by 164 · see citing works

Deficient Social and Play Behavior in Juvenile and Adult Rats after Neonatal Cortical Lesion: Effects of Chronic Pubertal Cannabinoid Treatment

Schneider, M., & Koch, M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300634 · Cited by 160 · see citing works

Comorbidity of Mood Disorders: A Longitudinal Prospective Study

Angst, J. (1996) · The British Journal of Psychiatry · doi:10.1192/s0007125000298383 · Cited by 160 · see citing works

Schizophrenia in users and nonusers of cannabis

Andréasson, S., Alle­beck, P., & Rydberg, U. S. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb10296.x · Cited by 157 · see citing works

The short-term consequences of early onset cannabis use

Fergusson, D. M., Lynskey, M. T., & Horwood, L. J. (1996) · Research on Child and Adolescent Psychopathology · doi:10.1007/bf01441571 · Cited by 157 · see citing works

Different Effects of Nabilone and Cannabidiol on Binocular Depth Inversion in Man

Leweke, F. M., Schneider, U., Radwan, M., Schmidt, E., & Emrich, H. M. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00201-x · Cited by 150 · see citing works

Effects of Co-occurring Alcohol Abuse on the Course of Bipolar Disorder Following a First Hospitalization for Mania

Strakowski, S. M., DelBello, M. P., Fleck, D. E., Adler, C. M., Anthenelli, R. M., Keck, P. E., Arnold, L. M., & Amicone, J. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.8.851 · Cited by 147 · see citing works

Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism

Paton, W. D. M., & Pertwee, R. G. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb07261.x · Cited by 134 · see citing works

Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential

Ashton, C. H., Moore, P. B., Gallagher, P., & Young, A. H. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105051541 · Cited by 132 · see citing works

Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?

di Forti, M., Morrison, P., Butt, A., & Murray, R. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3280fa838e · Cited by 120 · see citing works

Involvement of the Endocannabinoid System in the Ability of Long-Term Tricyclic Antidepressant Treatment to Suppress Stress-Induced Activation of the Hypothalamic–Pituitary–Adrenal Axis

Hill, M. N., Ho, W. ‐. V., Sinopoli, K. J., Viau, V., Hillard, C. J., & Gorzalka, B. B. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301092 · Cited by 116 · see citing works

Substance Abuse in First-Episode Bipolar I Disorder: Indications for Early Intervention

Baethge, C., Baldessarini, R. J., Khalsa, H.-M. K., Hennen, J. A., Salvatore, P., & Tohen, M. F. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.5.1008 · Cited by 112 · see citing works

Effects of synthetic Δ 9 -tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man

Leweke, F. M., Schneider, U., Thies, M., Münte, T. F., & Emrich, H. M. (1999) · Psychopharmacology · doi:10.1007/s002130050884 · Cited by 102 · see citing works

Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells

Allister, S. D. M., Chan, C. C., Taft, R. J., Luu, T., Abood, M. E., Moore, D. H., Aldape, K., & Yount, G. L. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-5950-2 · Cited by 102 · see citing works

Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-na??ve and plus-maze-experienced mice

Rodgers, R. J., Evans, P., & Murphy, A. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00013 · Cited by 98 · see citing works

Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness

Koethe, D., Gerth, C. W., Neatby, M. A., Haensel, A., Thies, M., Schneider, U., Emrich, H. M., Klosterkötter, J., Schultze-Lutter, F., & Leweke, F. M. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.07.023 · Cited by 93 · see citing works

Cannabinoid modulation of rat pup ultrasonic vocalizations

McGregor, I. S., Dastur, F. N., McLellan, R. A., & Brown, R. E. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00511-0 · Cited by 88 · see citing works

The development of suicide ideation and attempts: an epidemiologic study of first graders followed into young adulthood.

Wilcox, H. C., & Anthony, J. C. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.08.007 · Cited by 88 · see citing works

The Involvement of Glutamate in the Pathophysiology of Depression

Pałucha-Poniewiera, A., & Pilc, A. (2005) · Drug News & Perspectives · doi:10.1358/dnp.2005.18.4.908661 · Cited by 86 · see citing works

Cannabis and neurodevelopment: implications for psychiatric disorders

Sundram, S. (2006) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.762 · Cited by 86 · see citing works

Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats

Verrico, C. D., Jentsch, J. D., & Roth, R. H. (2003) · Synapse · doi:10.1002/syn.10215 · Cited by 79 · see citing works

Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2

Schneider, M., Drews, E., & Koch, M. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00018 · Cited by 72 · see citing works

Blockade of cannabinoid (CB1) receptors by SR 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils

Poncelet, M., Barnouin, M. C., Brelière, J.-C., Fur, G. L., & Soubrié, P. (1999) · Psychopharmacology · doi:10.1007/s002130050987 · Cited by 66 · see citing works

Effects of cannabinoids on the anxiety-like response in mice.

Rutkowska, M., Jamontt, J., & Gliniak, H. (2006) · PubMed · Cited by 66 · see citing works

Anger and Depressive States Among Treatment‐Seeking Drug Abusers: Testing the Psychopharmacological Specificity Hypothesis

Aharonovich, E., Nguyen, H. T., & Nunes, E. V. (2001) · American Journal on Addictions · doi:10.1111/j.1521-0391.2001.tb00522.x · Cited by 63 · see citing works

Rimonabant: A novel selective cannabinoid-1 receptor antagonist for treatment of obesity

Patel, P. N., & Pathak, R. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/060258 · Cited by 63 · see citing works

The Effects of Tetrahydrocannabinol on the Recognition of Emotionally Charged Words: An Analysis Using Event-Related Brain Potentials

Leweke, F. M., Kampmann, C., Radwan, M., Dietrich, D. E., Johannes, S., Emrich, H. M., & Münte, T. F. (1998) · Neuropsychobiology · doi:10.1159/000026487 · Cited by 44 · see citing works

The seed and the soil: effect of dosage, personality and starting state on the response to delta 9 tetrahydrocannabinol in man.

Ashton, H., Golding, J. B., Marsh, V. R., Millman, J. E., & Thompson, J. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01294.x · Cited by 42 · see citing works

Modulation of Δ9-THC-induced increase of cortical and hippocampal acetylcholine release by μ opioid and D1 dopamine receptors

Pisanu, A., Acquas, E., Fenu, S., & Chiara, G. D. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.023 · Cited by 38 · see citing works

Neurobiological aspects of depressive disorder and antidepressant treatment: role of glia

Páv, M., Kovárů, H., Fišerová, A., Havrdová, E., & Lisá, V. (2008) · Physiological Research · doi:10.33549/physiolres.930990 · Cited by 34 · see citing works

Problems With Odds Ratios

Epstein, D. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.190-a · Cited by 5 · see citing works

Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study

Neumeister, A., Normandin, M. D., Pietrzak, R. H., Piomelli, D., Zheng, M. Q., Gujarro-Anton, A., Potenza, M. N., Bailey, C. R., Lin, S. F., Najafzadeh, S., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.61 · Cited by 361 · see citing works

Chemistry, metabolism, and toxicology of cannabis: clinical implications.

Sharma, P., Murthy, P., & Bharath, M. M. S. (2012) · Europe PMC (PubMed Central) · Cited by 324 · see citing works

Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure

Schneider, M. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00110.x · Cited by 330 · see citing works

Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions

Lafourcade, M., Larrieu, T., Mato, S., Duffaud, A. M., Sepers, M. D., Matias, I., Smedt, V. D., Labrousse, V. F., Brétillon, L., Matute, C., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2736 · Cited by 314 · see citing works

A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population- a meta-analysis of 31 studies

Kedzior, K. K., & Laeber, L. T. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-136 · Cited by 309 · see citing works

CB1 Cannabinoid Receptors and their Associated Proteins

Howlett, A. C., Blume, L. C., & Dalton, G. D. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980023 · Cited by 296 · see citing works

Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.

El‐Alfy, A. T., Ivey, K., Robinson, K., Ahmed, S. A., Radwan, M. M., Slade, D., Khan, I. A., ElSohly, M. A., & Ross, S. A. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.03.004 · Cited by 271 · see citing works

A systematic review of the antipsychotic properties of cannabidiol in humans

Iseger, T. A., & Bossong, M. G. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.033 · Cited by 261 · see citing works

Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models

Malone, D. T., Hill, M. N., & Rubino, T. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00721.x · Cited by 237 · see citing works

A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation

Waldo Zuardi, A., Alexandre S. Crippa, J., E.C. Hallak, J., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., K. McGuire, P., & Silveira Guimaraes, F. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884681 · Cited by 222 · see citing works

Cannabis use and mania symptoms: A systematic review and meta-analysis

Gibbs, M., Winsper, C., Marwaha, S., Gilbert, E., Broome, M. R., & Singh, S. P. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.016 · Cited by 216 · see citing works

Epigenetic Effects of Cannabis Exposure

Szutorisz, H., & Hurd, Y. L. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.09.014 · Cited by 215 · see citing works

Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis

Girshkin, L., Matheson, S. L., Shepherd, A. M., & Green, M. J. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.013 · Cited by 215 · see citing works

Parental THC Exposure Leads to Compulsive Heroin-Seeking and Altered Striatal Synaptic Plasticity in the Subsequent Generation

Szutorisz, H., DiNieri, J. A., Sweet, E. S., Egervári, G., Michaelides, M., Carter, J. M., Ren, Y., Miller, M. L., Blitzer, R. D., & Hurd, Y. L. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.352 · Cited by 197 · see citing works

Endocannabinoids in Amygdala and Nucleus Accumbens Mediate Social Play Reward in Adolescent Rats

Trezza, V., Damsteegt, R., Manduca, A., Petrosino, S., Van Kerkhof, L. W. M., Pasterkamp, R. J., Zhou, Y., Campolongo, P., Cuomo, V., Di Marzo, V., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0114-12.2012 · Cited by 190 · see citing works

Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis

Koethe, D., Giuffrida, A., Schreiber, D., Hellmich, M., Schultze‐Lutter, F., Ruhrmann, S., Klosterkötter, J., Piomelli, D., & Leweke, F. M. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.053843 · Cited by 178 · see citing works

Lipids in Psychiatric Disorders and Preventive Medicine

Schneider, M., Levant, B., Reichel, M., Gulbins, E., Kornhuber, J., & Müller, C. P. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.002 · Cited by 175 · see citing works

Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks

Sherva, R., Wang, Q., Kranzler, H. R., Zhao, H., Koesterer, R., Herman, A. I., Farrer, L. A., & Gelernter, J. E. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0036 · Cited by 170 · see citing works

Comorbidity of bipolar and substance use disorders in national surveys of general populations, 1990–2015: Systematic review and meta-analysis

Hunt, G. E., Malhi, G. S., Cleary, M., Lai, H. M. X., & Sitharthan, T. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.051 · Cited by 161 · see citing works

Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats

Haller, J., Barna, I., Barsvari, B., Gyimesi Pelczer, K., Yasar, S., Panlilio, L. V., & Goldberg, S. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1494-7 · Cited by 159 · see citing works

Comorbid Cannabis Use Disorder with Major Depression and Generalized Anxiety Disorder: A Systematic Review with Meta-analysis of Nationally Representative Epidemiological Surveys

Onaemo, V. N., Fawehinmi, T. O., & D'Arcy, C. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.12.043 · Cited by 152 · see citing works

PTSD: from neurobiology to pharmacological treatments

Kelmendi, B., Adams, T., Yarnell, S. C., Southwick, S., Abdallah, C., & Krystal, J. (2016) · European Journal of Psychotraumatology · doi:10.3402/ejpt.v7.31858 · Cited by 136 · see citing works

Critical age windows for neurodevelopmental psychiatric disorders: evidence from animal models

Marco, E. M., Macrì, S., & Laviola, G. (2011) · Neurotoxicity Research · doi:10.1007/s12640-010-9205-z · Cited by 144 · see citing works

Early maternal deprivation induces gender‐dependent changes on the expression of hippocampal CB1 and CB2 cannabinoid receptors of neonatal rats

Suárez, J., Llorente, R., Romero‐Zerbo, S., Mateos, B., Bermúdez‐Silva, F. J., de Fonseca, F. R., & Viveros, M. (2008) · Hippocampus · doi:10.1002/hipo.20537 · Cited by 142 · see citing works

Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function

Cabral, G. A., Rogers, T. J., & Lichtman, A. H. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9615-z · Cited by 141 · see citing works

Cannabis use and cannabis use disorders among individuals with mental illness

Lev‐Ran, S., Foll, B. L., McKenzie, K. J., George, T. P., & Rehm, J. T. (2013) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2012.12.021 · Cited by 140 · see citing works

Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects

Marco, E. M. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00063 · Cited by 136 · see citing works

How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review

Hoch, E., Niemann, D., von Keller, R., Schneider, M., Friemel, C. M., Preuss, U. W., Hasan, A., & Pogarell, O. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-00984-4 · Cited by 131 · see citing works

High times for cannabis: Epigenetic imprint and its legacy on brain and behavior

Szutorisz, H., & Hurd, Y. L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.011 · Cited by 129 · see citing works

Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD)

Hallak, J. E. C., Machado‐de‐Sousa, J. P., Crippa, J. A. S., Sanches, R. F., Trzesniak, C. M. F., Chaves, C., Bernardo, S. A., Regalo, S. C. H., & Zuardi, A. W. (2010) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462010000100011 · Cited by 125 · see citing works

The endocannabinoid system in critical neurodevelopmental periods: sex differences and neuropsychiatric implications

Viveros, M., Llorente, R., Suárez, J., Llorente‐Berzal, A., López‐Gallardo, M., & de Fonseca, F. R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408956 · Cited by 124 · see citing works

Psychosis reactivity to cannabis use in daily life: an experience sampling study

Henquet, C., van Os, J., Kuepper, R., Delespaul, P., Smits, M., Campo, J. Á., & Myin‐Germeys, I. (2010) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.109.072249 · Cited by 121 · see citing works

Mitigation of post‐traumatic stress symptoms by <i>Cannabis</i> resin: A review of the clinical and neurobiological evidence

Passie, T., Emrich, H. M., Karst, M., Brandt, S. D., & Halpern, J. H. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1377 · Cited by 117 · see citing works

Cannabis use in children and adolescents with first episode psychosis: Influence on psychopathology and short-term outcome (CAFEPS study)

Baeza, I., Graell, M., Moreno, D. M., Castro‐Fornieles, J., Parellada, M., González-Pinto, A. M., Payá, B., Soutullo, C. A., de la Serna, E., & Arango, C. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.04.005 · Cited by 116 · see citing works

Marijuana: Current Concepts†

Greydanus, D. E., Hawver, E. K., Greydanus, M. M., & Merrick, J. (2013) · Frontiers in Public Health · doi:10.3389/fpubh.2013.00042 · Cited by 112 · see citing works

Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia

Ceccarini, J., Binder, M. D., van Winkel, R., Peuskens, J., Bormans, G. M., Kranaster, L., Enning, F., Koethe, D., Leweke, F. M., & Laere, K. V. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.04.052 · Cited by 108 · see citing works

Cannabis consumption and psychosis or schizophrenia development

Ortiz-Medina, M. B., Perea-Ortueta, M., Torales, J. C., Ventriglio, A., Vitrani, G., Aguilar, L., & Roncero, C. (2018) · International Journal of Social Psychiatry · doi:10.1177/0020764018801690 · Cited by 108 · see citing works

An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease

Wilsey, B. L., Marcotte, T. D., Deutsch, R., Zhao, H. H., Prasad, H., & Phan, A. T. (2016) · Journal of Pain · doi:10.1016/j.jpain.2016.05.010 · Cited by 100 · see citing works

Therapeutic Potential of Cannabinoids in Psychosis

Leweke, F. M., Mueller, J. K., Lange, B., & Rohleder, C. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.018 · Cited by 92 · see citing works

Smoking, alcohol consumption, and drug use among adolescents with psychiatric disorders compared with a population based sample

Mangerud, W. L., Bjerkeset, O. A., Holmen, T. L., Lydersen, S., & Indredavik, M. S. (2014) · Journal of Adolescence · doi:10.1016/j.adolescence.2014.08.007 · Cited by 91 · see citing works

Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction

Rodríguez-Muñoz, M., Sánchez‐Blázquez, P., Merlos, M., & Garzón-Niño, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10095 · Cited by 87 · see citing works

Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats

Sciolino, N. R., Bortolato, M., Eisenstein, S. A., Fu, J., Oveisi, F., Hohmann, A. G., & Piomelli, D. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.007 · Cited by 89 · see citing works

Endocannabinoids in brain plasticity: Cortical maturation, HPA axis function and behavior

Dow-Edwards, D. L., & Silva, L. (2016) · Brain Research · doi:10.1016/j.brainres.2016.08.037 · Cited by 84 · see citing works

Uso terapêutico dos canabinoides em psiquiatria

Crippa, J. A. S., Zuardi, A. W., & Hallak, J. E. C. (2010) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462010000500009 · Cited by 85 · see citing works

Cannabis involvement in individuals with bipolar disorder

Arpana Agrawal, A., Nürnberger, J. I., & Lynskey, M. T. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.07.007 · Cited by 85 · see citing works

The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids

Boucher, A. A., Hunt, G. E., Micheau, J., Huang, X., McGregor, I. S., Karl, T., & Arnold, J. C. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571000091x · Cited by 79 · see citing works

A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia

D’Addario, C., Micale, V., Bartolomeo, M. D., Štark, T., Pucci, M., Šulcová, A., Palazzo, C., Babinská, Z., Cremaschi, L., Drago, F., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.022 · Cited by 79 · see citing works

Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice

Busquets-García, A., Gómez, E. S., Redon, B., Mackenbach, Y., Vallée, M., Chaouloff, F., Varilh, M., Ferreira, G., Piazza, P.-V., & Marsicano, G. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.4 · Cited by 78 · see citing works

The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review

Batalla, A., Janssen, H., Gangadin, S. S., & Bossong, M. G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071058 · Cited by 77 · see citing works

Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder

Neumeister, A., Seidel, J., Ragen, B., & Pietrzak, R. H. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.10.012 · Cited by 76 · see citing works

Acute and Non-acute Effects of Cannabis on Human Memory Function: A Critical Review of Neuroimaging Studies

Bossong, M. G., Jager, G., Bhattacharyya, S., & Allen, P. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990436 · Cited by 73 · see citing works

Default Mode Network in the Effects of Δ9-Tetrahydrocannabinol (THC) on Human Executive Function

Bossong, M. G., Jansma, J. M., van Hell, H. H., Jager, G., Kahn, R. S., & Ramsey, N. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070074 · Cited by 73 · see citing works

Maternal deprivation and adolescent cannabinoid exposure impact hippocampal astrocytes, CB1 receptors and brain-derived neurotrophic factor in a sexually dimorphic fashion

López‐Gallardo, M., López-Rodríguez, A. B., Llorente‐Berzal, A., Rotllant, D., Mackie, K., Armario, A., Nadal, R. A., & Viveros, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.063 · Cited by 71 · see citing works

Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis

Schuelert, N., Johnson, M. P., Oskins, J. L., Jassal, K., Chambers, M. G., & McDougall, J. J. (2011) · Pain · doi:10.1016/j.pain.2010.11.025 · Cited by 70 · see citing works

Nutritional n-3 PUFA Deficiency Abolishes Endocannabinoid Gating of Hippocampal Long-Term Potentiation

Thomazeau, A., Bosch‐Bouju, C., Manzoni, O. J., & Layé, S. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw052 · Cited by 69 · see citing works

The association between adolescent cannabis use and anxiety: A parallel process analysis

Duperrouzel, J. C., Hawes, S. W., Lopez‐Quintero, C., Pacheco‐Colón, I., Comer, J. S., & González, R. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.11.005 · Cited by 66 · see citing works

Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans

Chadwick, V. L., Rohleder, C., Koethe, D., & Leweke, F. M. (2019) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000562 · Cited by 65 · see citing works

The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives

Marco, E. M., & Laviola, G. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408459 · Cited by 65 · see citing works

The neuropharmacology of cannabinoid receptor ligands in central signaling pathways

Brunt, T. M., & Bossong, M. G. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14982 · Cited by 61 · see citing works

NMDA Receptors, mGluR5, and Endocannabinoids are Involved in a Cascade Leading to Hippocampal Long-Term Depression

Izumi, Y., & Zorumski, C. F. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.243 · Cited by 61 · see citing works

Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor

Minocci, D., Massei, J., Martino, A., Milianti, M., Piz, L., Bello, D. D., Sbrana, A., Martinotti, E., Rossi, A. M., & Nieri, P. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.05.023 · Cited by 61 · see citing works

Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats

Spano, M. S., Fadda, P., Frau, R., Fattore, L., & Fratta, W. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.09.004 · Cited by 59 · see citing works

Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC).

Bossong, M., Jansma, J., Bhattacharyya, S., & Ramsey, N. (2014) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.11.017 · Cited by 58 · see citing works

Cannabinoid modulation of limbic forebrain noradrenergic circuitry

Carvalho, A. F., Mackie, K., & Bockstaele, E. J. V. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07054.x · Cited by 58 · see citing works

Synaptic Targets of 9-Tetrahydrocannabinol in the Central Nervous SystemPreprint

Hoffman, A. F., & Lupica, C. R. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012237 · Cited by 57 · see citing works

Cannabis use and first manic episode

Bally, N., ZULLINO, D. F., & Aubry, J. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.038 · Cited by 57 · see citing works

Immune system: A possible nexus between cannabinoids and psychosis

Suárez‐Pinilla, P., López-Gil, J., & Crespo‐Facorro, B. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.01.018 · Cited by 55 · see citing works

Medical use of cannabis. Cannabidiol: A new light for schizophrenia?

Deiana, S. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1425 · Cited by 52 · see citing works

Early-Life Adversity, Systemic Inflammation and Comorbid Physical and Psychiatric Illnesses of Adult Life

Nettis, M. A., Pariante, C. M., & Mondelli, V. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_89 · Cited by 53 · see citing works

Cortical thinness and volume differences associated with marijuana abuse in emerging adults

Mashhoon, Y., Sava, S., Sneider, J. T., Nickerson, L. D. H., & Silveri, M. M. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.06.016 · Cited by 50 · see citing works

The Cannabidiol Use in the Treatment of Epilepsy

Matos, R. L. A., Spinola, L. A., Barboza, L. L., Garcia, D. R., França, T. C. C., & Affonso, R. S. (2017) · Revista Virtual de Química · doi:10.21577/1984-6835.20170049 · Cited by 49 · see citing works

Early maternal deprivation induces changes on the expression of 2-AG biosynthesis and degradation enzymes in neonatal rat hippocampus

Suárez, J., Rivera, P., Llorente, R., Romero‐Zerbo, S., Bermúdez‐Silva, F. J., de Fonseca, F. R., & Viveros, M. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.042 · Cited by 48 · see citing works

Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic nervous system?

Richards, J. R. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.04.018 · Cited by 48 · see citing works

THE ENDOCANNABINOID SYSTEM PROVIDES AN AVENUE FOR EVIDENCE-BASED TREATMENT DEVELOPMENT FOR PTSD: The Cutting Edge: Evidence-Based Treatment Developments for PTSD

Neumeister, A. (2013) · Depression and Anxiety · doi:10.1002/da.22031 · Cited by 47 · see citing works

Impact of substance use on the physical health of patients with bipolar disorder

García‐Portilla, M. P., Sáiz, P. A., Benabarre, A., Flórez, G., Bobes-Bascarán, T., Díaz, E. M. F., Bousoño, M., & Bobes, J. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01498.x · Cited by 47 · see citing works

The endocannabinoid system as a target for modelling psychosis

Koethe, D., Hoyer, C., & Leweke, F. M. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1591-7 · Cited by 47 · see citing works

Is there a role for cannabidiol in psychiatry?

Khoury, J. M., das Neves, M. D. C. L., Roque, M. A. V., Queiroz, D. A. D. B., de Freitas, A. A. C., de Fátima, Â., Moreira, F. A., & Garcia, F. D. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1285049 · Cited by 45 · see citing works

Cannabis use and psychotic‐like experiences trajectories during early adolescence: the coevolution and potential mediators

Bourque, J., Afzali, M. H., O’Leary-Barrett, M., & Conrod, P. (2017) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12765 · Cited by 45 · see citing works

Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence

Bright, U., & Akirav, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105526 · Cited by 47 · see citing works

Prospects for the Use of Cannabinoids in Psychiatric Disorders

Graczyk, M., Łukowicz, M., & Dzierżanowski, T. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.620073 · Cited by 45 · see citing works

Effects of ∆9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies

Raymundi, A. M., da Silva, T. R., Sohn, J. M. B., Bertoglio, L. J., & Stern, C. A. J. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02813-8 · Cited by 40 · see citing works

Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology

Hudson, R., Rushlow, W. J., & Laviolette, S. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4766-7 · Cited by 33 · see citing works

Psychotic experiences are linked to cannabis use in adolescents in the community because of common underlying environmental risk factors

Shakoor, S., Zavos, H. M. S., McGuire, P. K., Cardno, A. G., Freeman, D. H., & Ronald, A. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.03.041 · Cited by 38 · see citing works

Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: Drug-discovery strategies

Janero, D. R., Vadivel, S. K., & Makriyannis, A. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782778 · Cited by 38 · see citing works

Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia

Morris, G., Sominsky, L., Walder, K. R., Berk, M., Marx, W., Carvalho, A. F., Bortolasci, C. C., Maes, M. H. J., & Puri, B. K. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02800-y · Cited by 37 · see citing works

In vivo pharmacology of endocannabinoids and their metabolic inhibitors: Therapeutic implications in Parkinson's disease and abuse liability

Giuffrida, A., & McMahon, L. R. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.05.004 · Cited by 35 · see citing works

Impact of Acute and Chronic Cannabis Use on Stress Response Regulation: Challenging the Belief That Cannabis Is an Effective Method for Coping

al'Absi, M., & Allen, A. M. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.687106 · Cited by 34 · see citing works

A review of Indian research on co-occurring cannabis use disorders & psychiatric disorders

Singh, S., & Balhara, Y. P. S. (2017) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_791_15 · Cited by 33 · see citing works

Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models

van Enkhuizen, J., Geyer, M. A., Minassian, A., Perry, W., Henry, B. L., & Young, J. W. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.08.008 · Cited by 31 · see citing works

Psychotic spectrum disorders: Definitions, classifications, neural correlates and clinical profiles

Giulio, P. (2020) · Annals of Psychiatry and Treatment · doi:10.17352/apt.000023 · Cited by 33 · see citing works

Comorbidades psiquiátricas em dependentes químicos em abstinência em ambiente protegido

Hess, A. R. B., de Almeida, R. M. M., & Moraes, A. L. (2012) · Estudos de Psicologia (Natal) · doi:10.1590/s1413-294x2012000100021 · Cited by 32 · see citing works

Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions

Zádor, F., Nagy-Grócz, G., Kékesi, G., Dvorácskó, S., Szűcs, E., Tömböly, C., Horváth, G., Benyhe, S., & Vécsei, L. (2019) · Molecules · doi:10.3390/molecules24203709 · Cited by 32 · see citing works

Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry

Maremmani, I., Maremmani, A. G. I., Rugani, F., Rovai, L., Pacini, M., Bacciardi, S., Deltito, J. A., Dell’Osso, L., & Akiskal, H. S. (2012) · Annals of General Psychiatry · doi:10.1186/1744-859x-11-23 · Cited by 32 · see citing works

Translational models of cannabinoid vapor exposure in laboratory animals

Moore, C. F., Stiltner, J. W., Davis, C. M., & Weerts, E. M. (2020) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000592 · Cited by 31 · see citing works

Alcohol use disorders are associated with increased affective lability in bipolar disorder

Lagerberg, T. V., Aminoff, S. R., Aas, M., Bjella, T. D., Henry, C., Leboyer, M., Pedersen, G., Bellivier, F., Icick, R., Andreassen, O. A., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.09.062 · Cited by 30 · see citing works

Brain circuitry associated with the development of substance use in bipolar disorder and preliminary evidence for sexual dimorphism in adolescents

Lippard, E., Mazure, C. M., Johnston, J. A. Y., Spencer, L., Weathers, J., Pittman, B. P., Wang, F., & Blumberg, H. P. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23901 · Cited by 29 · see citing works

Bipolar disorder and the endocannabinoid system

Arjmand, S., Behzadi, M., Kohlmeier, K. A., Mazhari, S., Sabahi, A., & Shabani, M. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.21 · Cited by 29 · see citing works

Neurological soft signs in non‐psychotic patients with cannabis dependence

Dervaux, A., Bourdel, M., Laqueille, X., & Krebs, M. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00261.x · Cited by 26 · see citing works

Endocannabinoids: Stress, Anxiety, and Fear

Taber, K. H., & Hurley, R. A. (2009) · Journal of Neuropsychiatry · doi:10.1176/jnp.2009.21.2.iv · Cited by 27 · see citing works

Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase

Fišar, Z. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.010 · Cited by 27 · see citing works

Cannabinoids and schizophrenia

Rohleder, C., & Leweke, F. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417041-4.00008-4 · Cited by 2 · see citing works

Schizophrenia

Leweke, F. M. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7_16

The acute effects of cannabinoids in patients with psychotic illness

Henquet, C., Sewell, A., Kuepper, R., Ranganathan, M., & D’Souza, D. C. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511706080.019

Cannabis-induced bipolar disorder with psychotic features: a case report.

Khan, M. A., & Akella, S. (2009) · PubMed Central · Cited by 23 · see citing works

Cannabinoids and Schizophrenia: Risks and Therapeutic Potential

Manseau, M. W., & GOFF, D. C. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0382-6 · Cited by 56 · see citing works